93.4% Below Target

The consensus Wall Street price target for UPBD is $39.67, representing 93.4% upside from the current price of $20.51. With 20 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

UPBD has a consensus rating of "Buy" based on 20 Wall Street analysts. The rating breakdown is predominantly bullish, with 16 Buy/Strong Buy ratings. The consensus 12-month price target of $39.67 implies 93.4% upside from current levels.

With a forward P/E of 4.885x, UPBD trades at a relatively low valuation. The consensus target of $39.67 implies 93.4% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $45 for UPBD, while the most conservative target is $33. The consensus of $39.67 represents the median expectation. Our quantitative valuation model projects a bull case target of $39 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

UPBD is well covered by analysts, with 20 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 16 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month UPBD stock forecast based on 20 Wall Street analysts shows a consensus price target of $39.67, with estimates ranging from $33 (bear case) to $45 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $30, with bear/bull scenarios of $19/$39.

Our quantitative valuation model calculates UPBD's fair value at $30 (base case), with a bear case of $19 and bull case of $39. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 46/100.

UPBD trades at a forward P/E ratio of 4.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 16.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on UPBD, with a "Buy" consensus rating and $39.67 price target (93.4% upside). 16 of 20 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

UPBD analyst price targets range from $33 to $45, a 30% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $39.67 consensus represents the middle ground. Our model's $19-$39 range provides an independent fundamental perspective.